Sarah Raissi, PhD
Associate Specialist
Neurology
School of Medicine

Grants and Projects

Show all (1) Hide

• Myo-inositol regulation of myelination in development and hypoxic newborn brain injury, NIH, 2019-2022

Publications (6)

Top publication keywords:
Neural PathwaysProto-Oncogene Proteins c-bcl-2Wallerian DegenerationAxonsMyelin SheathWhite MatterNeuronal PlasticityInositol 1,4,5-Trisphosphate ReceptorsNerve DegenerationPaclitaxelCatatoniaRemyelinationF-Box-WD Repeat-Containing Protein 7OligodendrogliaCytoskeleton

• Re-WRAP (Remyelination for women at risk of axonal loss and progression): A phase II randomized placebo-controlled delayed-start trial of bazedoxifene for myelin repair in multiple sclerosis.
  Contemporary clinical trials 2023 Nylander A, Anderson A, Rowles W, Hsu S, Lazar AA, Mayoral SR, Pease-Raissi SE, Green A, Bove R
• Building a (w)rapport between neurons and oligodendroglia: Reciprocal interactions underlying adaptive myelination.
  Neuron 2021 Pease-Raissi SE, Chan JR
• Myelinating Schwann cells ensheath multiple axons in the absence of E3 ligase component Fbxw7.
  Nature communications 2019 Harty BL, Coelho F, Pease-Raissi SE, Mogha A, Ackerman SD, Herbert AL, Gereau RW, Golden JP, Lyons DA, Chan JR, Monk KR
• Micro(glial)-managing executive function: white matter inflammation drives catatonia.
  The Journal of clinical investigation 2017 Pease-Raissi SE, Chan JR
• Paclitaxel Reduces Axonal Bclw to Initiate IP3R1-Dependent Axon Degeneration.
  Neuron 2017 Pease-Raissi SE, Pazyra-Murphy MF, Li Y, Wachter F, Fukuda Y, Fenstermacher SJ, Barclay LA, Bird GH, Walensky LD, Segal RA
• Preserve and protect: maintaining axons within functional circuits.
  Trends in neurosciences 2014 Pease SE, Segal RA